Share of pregnant women with HIV that receive antiretroviral therapy in Yemen

Yemen: Share of pregnant women with HIV that receive antiretroviral therapy was 11.0% in 2024. ◆ Volatile

Latest (2024)
11.0%
Change on year
down 15.4%
World rank
83rd
of 84 countries
All-time high
14.0%
in 2022
All-time low
0.0%
in 2000
Years of data
24
2000–2024

Share of pregnant women with HIV that receive antiretroviral therapy in Yemen, 2000–2024

0510152000201220242000: 0 % of pregnant women living with HIV2001: 0 % of pregnant women living with HIV2002: 0 % of pregnant women living with HIV2003: 0 % of pregnant women living with HIV2004: 0 % of pregnant women living with HIV2005: 0 % of pregnant women living with HIV2006: 0 % of pregnant women living with HIV2007: 1 % of pregnant women living with HIV2008: 1 % of pregnant women living with HIV2009: 5 % of pregnant women living with HIV2010: 6 % of pregnant women living with HIV2011: 2 % of pregnant women living with HIV2012: 4 % of pregnant women living with HIV2013: 5 % of pregnant women living with HIV2014: 5 % of pregnant women living with HIV2015: 4 % of pregnant women living with HIV2017: 4 % of pregnant women living with HIV2018: 3 % of pregnant women living with HIV2019: 3 % of pregnant women living with HIV2020: 2 % of pregnant women living with HIV2021: 4 % of pregnant women living with HIV2022: 14 % of pregnant women living with HIV2023: 13 % of pregnant women living with HIV2024: 11 % of pregnant women living with HIV

Source: UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Measured in % of pregnant women living with HIV.

Analysis

Yemen recorded 11.0% for share of pregnant women with hiv that receive antiretroviral therapy in 2024.

That represents a change of down 15.4% on the previous year and up 120.0% over ten years.

Over the whole period, share of pregnant women with hiv that receive antiretroviral therapy in Yemen peaked at 14.0% in 2022 and was at its lowest, 0.0%, in 2000.

Yemen ranks 83rd of 84 countries on this measure, in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Share of pregnant women with HIV that receive antiretroviral therapy in Yemen, year by year

Annual values for Share of pregnant women with HIV that receive antiretroviral therapy in Yemen, 2000 to 2024.
Year % of pregnant women living with HIV Change
2000 0.0% —
2001 0.0% —
2002 0.0% —
2003 0.0% —
2004 0.0% —
2005 0.0% —
2006 0.0% —
2007 1.0% —
2008 1.0% +0.0%
2009 5.0% +400.0%
2010 6.0% +20.0%
2011 2.0% -66.7%
2012 4.0% +100.0%
2013 5.0% +25.0%
2014 5.0% +0.0%
2015 4.0% -20.0%
2017 4.0% +0.0%
2018 3.0% -25.0%
2019 3.0% +0.0%
2020 2.0% -33.3%
2021 4.0% +100.0%
2022 14.0% +250.0%
2023 13.0% -7.1%
2024 11.0% -15.4%

Yemen compared with similar countries

  • Yemen's 11.0% is below the median for low income countries, which is 73.0%, 15% of the median. (22 countries reporting)
  • Yemen's 11.0% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 32.0%, 34% of the median. (9 countries reporting)

Biggest year-on-year movements

Years where Share of pregnant women with HIV that receive antiretroviral therapy in Yemen changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2009 +400.0% 1.0% 5.0%
2022 +250.0% 4.0% 14.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 0.7% 0.0% 5.0% 10
2010s 4.0% 2.0% 6.0% 9
2020s 8.8% 2.0% 14.0% 5

Countries ranked near Yemen

  1. 80 Philippines 16.0% compare
  2. 81 Afghanistan 14.0% compare
  3. 81 Pakistan 14.0% compare
  4. 84 Sudan 5.0% compare

See the full ranking of 84 places →

More gender data for Yemen

All data for Yemen →

Frequently asked questions

What is share of pregnant women with hiv that receive antiretroviral therapy in Yemen?
Share of pregnant women with hiv that receive antiretroviral therapy in Yemen was 11.0% in 2024, according to UNAIDS estimates, via World Bank (2026) – processed by Our World in Data.
What is the highest share of pregnant women with hiv that receive antiretroviral therapy recorded in Yemen?
The highest recorded value was 14.0% in 2022.
What is the lowest share of pregnant women with hiv that receive antiretroviral therapy recorded in Yemen?
The lowest recorded value was 0.0% in 2000.
How does Yemen rank for share of pregnant women with hiv that receive antiretroviral therapy?
Yemen ranks 83rd out of 84 countries with data for 2024.
Is share of pregnant women with hiv that receive antiretroviral therapy rising or falling in Yemen?
Over the last ten years it is up 120.0%. The long-run trend across the full record is volatile.
Where does this Yemen data come from?
The figures come from UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as part of Share of pregnant women with HIV that receive antiretroviral therapy. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Share of pregnant women with HIV that receive antiretroviral therapy in Yemen. Statizoid, drawing on UNAIDS estimates, via World Bank (2026) – processed by Our World in Data. Retrieved 09 November 2026, from https://gender.statizoid.com/stat/art-coverage-for-pregnant-women/yemen-rep/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/art-coverage-for-pregnant-women/yemen-rep/">Share of pregnant women with HIV that receive antiretroviral therapy in Yemen</a> — Statizoid

About this data

Indicator
Share of pregnant women with HIV that receive antiretroviral therapy
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, via World Bank (2026) – processed by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
84 places, 2,030 data points, 2000–2024
Last refreshed

Antiretroviral medicine is used to prevent mother-to-child transmission of HIV.